Global Foot and Mouth Disease (FMD) Vaccine Market to Reach $5.6 Billion by 2030
The global market for Foot and Mouth Disease (FMD) Vaccine estimated at US$3.1 Billion in the year 2023, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 9% over the period 2023-2030. Conventional Vaccines, one of the segments analyzed in the report, is expected to record 7.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Emergency Vaccines segment is estimated at 10.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $803.9 Million, While China is Forecast to Grow at 13% CAGR
The Foot and Mouth Disease (FMD) Vaccine market in the U.S. is estimated at US$803.9 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 13% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 8% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook